Announcing a new publication for Acta Materia Medica journal. Zeqi (Euphorbia helioscopia L.), is a widely distributed plant of the Euphorbiaceae family. Zeqi is a famous Chinese herbal medicine with the effects of inducing diuresis for removing edema, killing pathogens and relieve itching, etc. It can be used to treat edema, dysentery, osteomyelitis, cancer and many other diseases.
With the development of processing and extraction technologies, a series of active substances have been extracted from Zeqi, including terpenes, steroids, tannins and flavonoids. Among these components, terpenes are the most abundant. Recent pharmacological studies indicated that Zeqi has multifunction including antitumor activity, antiviral activity, anti-inflammatory activity, anthelmintic activity, antibacterial activity, and antioxidant activity.
Pharmacological studies on Zeqi in recent years are summarized in this article to provide a more comprehensive analysis of the application of traditional Chinese medicine Zeqi in clinical treatment and modern medicine.
Read full article at Scienceopen: https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0050
Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
Submission Process
Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed
Queries about the journal can be sent to editorialoffice@amm-journal.org.
Please visit https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
There are no author submission or article processing fees.
Follow Acta Materia Medica on Twitter https://twitter.com/AMM_journal; Facebook (https://www.facebook.com/AMMjournal)
eISSN 2737-7946
Yanqi Liang, Xi Wang and Qing Sun et al. Preliminary study on Zeqi: from pharmacological action of active ingredients to clinical application research. Acta Materia Medica. 2024. Vol. 3(4):423-435. DOI: 10.15212/AMM-2024-0050.